Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience [PDF]
Dermatology and Therapy, 2021 Ellen J. Kim +2 more
exaly +2 more sources
Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study [PDF]
Dermatology and Therapy, 2022 Christiane Querfeld +2 more
exaly +2 more sources
Correction to: The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma. [PDF]
Am J Clin Dermatol, 2022 BACKGROUND: Chlormethine/mechlorethamine gel is a skin-directed therapy for patients with mycosis fungoides cutaneous T-cell lymphoma. Currently, real-world data on chlormethine gel are lacking.
Kim EJ +8 more
europepmc +2 more sources
Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides. [PDF]
Dermatol Ther (Heidelb), 2022 INTRODUCTION: Treatment of early-stage mycosis fungoides (MF) requires safe, skin-directed therapies. Medication side effects can lead to underutilization of effective therapies.
Alexander-Savino CV +4 more
europepmc +2 more sources
The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma [PDF]
American Journal of Clinical Dermatology, 2021 Joan Guitart +2 more
exaly +2 more sources
Dermatology, 2022 Mycosis fungoides (MF) is the most common form of cutaneous T-cell lymphoma. Patients can be treated using chlormethine gel, a skin-directed therapy developed and approved for MF.
Querfeld C +8 more
europepmc +2 more sources
Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience. [PDF]
Acta Derm Venereol, 2021 Mycosis fungoides is a type of cutaneous T-cell lymphoma, which accounts for the majority of cases of cutaneous T-cell lymphoma. Mycosis fungoides can be classified as early-stage (IA-IIA) or late-stage (IIB or greater) disease. In early-stage mycosis fungoides, skin-directed therapies are commonly used to manage the disease.
Garcia-Saleem TJ +3 more
europepmc +3 more sources
Expert Opinions and Clinical Experiences With Chlormethine Gel as Maintenance Treatment for Patients With Mycosis Fungoides [PDF]
, 2023 Maintenance treatment can be recommended for patients with mycosis fungoides (MF) whose disease responds to primary treatment. While positive outcomes have been observed in small studies with maintenance therapy, there is a lack of practical guidelines ...
Bagot, Martine +7 more
core +1 more source
Mycosis fungoides and Sézary syndrome – Review and outlook
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 21, Issue 4, Page 386-391, April 2023., 2023 Summary Mycosis fungoides and Sézary syndrome are the most important representatives of the heterogeneous group of cutaneous T‐cell lymphomas. The diseases are rare and the diagnosis, which always requires a clinical‐pathological correlation, is often delayed, especially in early forms of mycosis fungoides. The prognosis of mycosis fungoides depends on
Johanna Latzka, Franz Trautinger
wiley +1 more source
Asymptomatic erythematous plaque on the lower leg
, 2023 JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 21, Issue 7, Page 813-815, July 2023.
Inga Hansen +4 more
wiley +1 more source